comparemela.com

Latest Breaking News On - Kinnate biopharma - Page 1 : comparemela.com

Kinnate Biopharma Inc. (NASDAQ:KNTE) Given Average Recommendation of "Hold" by Analysts

Kinnate Biopharma Inc. (NASDAQ:KNTE) Given Average Recommendation of "Hold" by Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Stifel-nicolaus
William-blair
Kinnate-biopharma
Deltec-asset-management
Capital-management
Nasdaq
Kinnate-biopharma-inc
Acuitas-investments
Acadian-asset-management
Citigroup-inc
Get-free-report

Marquette Asset Management LLC Takes $142,000 Position in Kinnate Biopharma Inc. (NASDAQ:KNTE)

Marquette Asset Management LLC Takes $142,000 Position in Kinnate Biopharma Inc. (NASDAQ:KNTE)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
William-blair
Stifel-nicolaus
Kinnate-biopharma
Acuitas-investments
Citigroup-inc
Acadian-asset-management
Capital-management
Kinnate-biopharma-inc
Marquette-asset-management
Nasdaq
Free-report

Acuitas Investments LLC Invests $687,000 in Kinnate Biopharma Inc. (NASDAQ:KNTE)

Acuitas Investments LLC purchased a new position in Kinnate Biopharma Inc. (NASDAQ:KNTE – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 289,766 shares of the company’s stock, valued at approximately $687,000. Acuitas Investments LLC owned approximately 0.62% of Kinnate Biopharma […]

United-states
William-blair
Kinnate-biopharma
Stifel-nicolaus
Citigroup-inc
Capital-management
Acadian-asset-management
Acuitas-investments
Kinnate-biopharma-inc
Nasdaq
Connor-clark-lunn-investment-management-ltd
Free-report

Brokerages Set Kinnate Biopharma Inc. (NASDAQ:KNTE) Price Target at $11.72

Shares of Kinnate Biopharma Inc. (NASDAQ:KNTE – Get Free Report) have received an average rating of “Hold” from the six ratings firms that are presently covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12-month price […]

United-states
William-blair
Kinnate-biopharma
Stifel-nicolaus
Kinnate-biopharma-company-profile
Jpmorgan-chase-co
Metlife-investment-management
Kinnate-biopharma-inc
Blackrock-inc
Nasdaq
Get-free-report
Biopharma-stock-down

XOMA Corporation Announces Closing of Tender Offer

XOMA Corporation Announces Closing of Tender Offer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Wilson-sonsini-goodrich-rosati
Kathy-vincent
Juliane-snowden
Securities-exchange
Exchange-commission
Nasdaq-stock-market
Gibson
Nasdaq
Corporation-announces-closing-of-tender
Kinnate-biopharma-inc
Lazard
Dunn-crutcher

vimarsana © 2020. All Rights Reserved.